Filing Details
- Accession Number:
- 0001209191-11-022062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-06 18:50:37
- Reporting Period:
- 2011-04-04
- Filing Date:
- 2011-04-06
- Accepted Time:
- 2011-04-06 18:50:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411861 | Mako Surgical Corp. | MAKO | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 201901148 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1424202 | Morry S Blumenfeld | 2555 Davie Road Fort Lauderdale FL 33317 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-04-04 | 20,000 | $25.81 | 674,057 | No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
Common Stock | Disposition | 2011-04-05 | 10,000 | $25.38 | 664,057 | No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
Common Stock | Disposition | 2011-04-06 | 13,154 | $25.93 | 650,903 | No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
No | 4 | S | Indirect | By Ziegler Meditech Equity Partners, L.P. |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 72,147 | Indirect | By Meditech Advisors LLC |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ziegler Meditech Equity Partners, L.P. on March 4, 2011.
- The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $25.40 per share to $26.00 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- The reporting person is a member of the board of managers of Ziegler Meditech Partners, LLC, the general partner of Ziegler Meditech Equity Partners, L.P., but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $25.25 per share to $25.53 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- The price in Column 4 is a weighted average price per share. The shares were sold in multiple transasctions at prices ranging from $25.87 per share to $26.25 per share. The reporting person will provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
- The shares are held by Meditech Advisors LLC in trust for its partners. The partners of Meditech Advisors are Eitan Machover, Samuel Cubac, Grosvenor LLC and Allandale Ltd. The reporting person and certain of his family members constitute the members of Grosvenor LLC. As such, the reporting person may be deemed to be an indirect beneficial owner of these shares, but he disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.